157 related articles for article (PubMed ID: 9164337)
1. Losartan versus captopril in elderly patients with heart failure.
Sechi LA; Catena C; Bartoli E
Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164337
[No Abstract] [Full Text] [Related]
2. Losartan versus captopril in elderly patients with heart failure.
Ball SG
Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338
[No Abstract] [Full Text] [Related]
3. Losartan versus captopril in elderly patients with heart failure.
Jensen BV; Nielsen SL
Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335
[No Abstract] [Full Text] [Related]
4. Losartan versus captopril in elderly patients with heart failure.
Fournier A; Achard JM; Fernandez LA
Lancet; 1997 May; 349(9063):1473-4; author reply 1475. PubMed ID: 9164336
[No Abstract] [Full Text] [Related]
5. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
[TBL] [Abstract][Full Text] [Related]
6. Survival after myocardial infarction in rats: captopril versus losartan.
Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
[TBL] [Abstract][Full Text] [Related]
7. [Angiotensin II antagonist for heart insufficiency].
Z Kardiol; 1997 Jun; 86(6 Suppl):1-8. PubMed ID: 9259867
[No Abstract] [Full Text] [Related]
8. [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure].
Rakugi H; Ogihara T
Nihon Rinsho; 2001 Oct; 59(10):2051-61. PubMed ID: 11676153
[TBL] [Abstract][Full Text] [Related]
9. [ACE inhibitors or AT1 receptor antagonists?].
Riegger GA
Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
[No Abstract] [Full Text] [Related]
10. AT1-receptor antagonists for the treatment of chronic heart failure.
Baan J
Cardiovasc Res; 1999 Jan; 41(1):14-5. PubMed ID: 10325947
[No Abstract] [Full Text] [Related]
11. [Angiotensin-II-receptor antagonists for cardiac insufficiency].
Kromer EP
Internist (Berl); 2000 Sep; 41(9):917-24. PubMed ID: 11006881
[No Abstract] [Full Text] [Related]
12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor antagonists.
Goldsmith DJ
Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
[No Abstract] [Full Text] [Related]
14. The effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on obstructed rat bladder.
Palmer LS; Lee C; Decker RS; Lang S; Kaplan WE; Firlit CF; Cheng EY
J Urol; 1997 Sep; 158(3 Pt 2):1100-4. PubMed ID: 9258150
[TBL] [Abstract][Full Text] [Related]
15. [Medical angiotensin II-receptor blockade in hypertension and heart failure].
van Zwieten PA; Lie KI
Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1529-33. PubMed ID: 7675129
[No Abstract] [Full Text] [Related]
16. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
Pitt B; Chang P; Timmermans PB
Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
[TBL] [Abstract][Full Text] [Related]
17. [Evidence for the benefits of ACE inhibitors and AII antagonists in slowing progressive renal failure in diabetes].
Suzuki H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():323-8. PubMed ID: 12430248
[No Abstract] [Full Text] [Related]
18. Losartan in post-transplant erythrocytosis.
Conlon PJ; Smith SR; Butterly DW; Brennan DC
Nephrol Dial Transplant; 1996 Dec; 11(12):2524-5. PubMed ID: 9017645
[No Abstract] [Full Text] [Related]
19. Angiotensin receptor antagonists as a treatment for hypertension.
MacFadyen RJ; Reid JL
J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690
[No Abstract] [Full Text] [Related]
20. Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.
Parkhomenko AN; Irkin OI; Kushnir SP; Bryl ZV; Soliarik O; Shkliar LV
Acta Cardiol; 2002 Feb; 57(1):61-3. PubMed ID: 11918155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
